The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanism

Radiation Research

Volumn 177, Issue 1, 2012, Pages 18-24

  Mukherjee, Debayan ^a   Coates, Philip J ^a   Lorimore, Sally A ^a   Wright, Eric G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; ENERGY; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; IONIZING RADIATION; LEUKEMOGENESIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIATION EXPOSURE; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; BONE MARROW; CHROMOSOMAL INSTABILITY; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MICE; PYRAZOLES; SIGNAL TRANSDUCTION; SULFONAMIDES; TIME FACTORS;

EID: 84255167559     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2793.1     Document Type: Article

References (55)

1. Wright EG. Ionizing radiation and leukaemia: more questions than answers. Hematol Oncol 2005; 23:119-26. (Pubitemid 43061889)
2. Little JB. Genomic instability and bystander effects: a historical perspective. Oncogene 2003; 22:6978-87. (Pubitemid 37386665)
3. Lorimore SA, Coates PJ, Wright EG. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 2003; 22:7058-69. (Pubitemid 37386675)
4. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res 2003; 159:581-96. (Pubitemid 36539237)
5. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res 2003; 159:567-80. (Pubitemid 36539236)
6. Wright EG, Coates PJ. Untargeted effects of ionizing radiation: implications for radiation pathology. Mutat Res 2006; 597:119-32.
7. Wright EG. Manifestations and mechanisms of non-targeted effects of ionizing radiation. Mutat Res 2010; 687:28-33.
8. Watson GE, Pocock DA, Papworth D, Lorimore SA, Wright EG. In vivo chromosomal instability and transmissible aberrations in the progeny of haemopoietic stem cells induced by high- and low- LET radiations. Int J Radiat Biol 2001; 77:409-17. (Pubitemid 32281124)
9. Lorimore SA, McIlrath JM, Coates PJ, Wright EG. Chromosomal instability in unirradiated hemopoietic cells resulting from a delayed in vivo bystander effect of gamma radiation. Cancer Res 2005; 65:5668-73. (Pubitemid 40911168)
10. Coates PJ, Robinson JI, Lorimore SA, Wright EG. Ongoing activation of p53 pathway responses is a long-term consequence of radiation exposure in vivo and associates with altered macrophage activities. J Pathol 2008; 214:610-6. (Pubitemid 351482276)
11. Coates PJ, Rundle JK, Lorimore SA, Wright EG. Indirect macrophage responses to ionizing radiation: implications for genotype-dependent bystander signaling. Cancer Res 2008; 68:450-6. (Pubitemid 351380071)
12. Lorimore SA, Chrystal JA, Robinson JI, Coates PJ, Wright EG. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res 2008; 68:8122-6.
13. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med 1994; 16:99-109.
14. Lorimore SA, Wright EG. Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 2003; 79:15-25. (Pubitemid 36140233)
15. Mothersill C, Seymour C. Radiation-induced bystander effects: past history and future directions. Radiat Res 2001; 155:759-67. (Pubitemid 32494601)
16. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7. (Pubitemid 36019639)
17. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454:436-44.
18. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancerrelated inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30:1073-81.
19. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-99.
20. Walburg HE, Congreve GU, Upton AC. Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int J Cancer 1968; 3:150-4.
21. Yoshida K, Nemoto K, Nishimura M, Seki M. Exacerbating factors of radiation-induced myeloid leukemogenesis. Leuk Res 1993; 17:437-40. (Pubitemid 23154357)
22. Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, et al. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 2004; 64:3334-43. (Pubitemid 38581441)
23. Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, et al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neuinduced breast cancer. Cancer Res 2002; 62:5405-7.
24. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 2000; 60:5040-4.
25. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58:409-12. (Pubitemid 28087398)
26. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, et al. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 2000; 60:293-7. (Pubitemid 30070754)
27. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2010; 377:31-41.
28. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376:1741-50.
29. Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, et al. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine- induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 2000; 60:5599-602.
30. Save V, Coates PJ, Hall PA. Analysis of apoptosis in tissue sections. Methods Mol Biol 2001; 174:347-59.
31. Wright EG. Radiation-induced genomic instability in haemopoietic cells. Int J Radiat Biol 1998; 74:681-7. (Pubitemid 28566234)
32. Major IR. Induction of myeloid leukaemia by whole-body single exposure of CBA male mice to x-rays. Br J Cancer 1979; 40:903-13. (Pubitemid 10171538)
33. Major IR, Mole RH. Myeloid leukaemia in x-ray irradiated CBA mice. Nature 1978; 272:455-6. (Pubitemid 8307587)
34. Watson GE, Lorimore SA, Wright EG. Long-term in vivo transmission of alpha-particle-induced chromosomal instability in murine haemopoietic cells. Int J Radiat Biol 1996; 69:175-82. (Pubitemid 26132790)
35. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428-35.
36. Seymour CB, Mothersill C, Alper T. High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1986; 50:167-79. (Pubitemid 16065783)
37. Chang WP, Little JB. Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Int J Radiat Biol 1991; 60:483-96.
38. Mothersill C, Kadhim MA, O'Reilly S, Papworth D, Marsden SJ, Seymour CB, et al. Dose- and time-response relationships for lethal mutations and chromosomal instability induced by ionizing radiation in an immortalized human keratinocyte cell line. Int J Radiat Biol 2000; 76:799-806. (Pubitemid 30352763)
39. Limoli CL, Hartmann A, Shephard L, Yang CR, Boothman DA, Bartholomew J, et al. Apoptosis, reproductive failure, and oxidative stress in Chinese hamster ovary cells with compromised genomic integrity. Cancer Res 1998; 58:3712-8. (Pubitemid 28376573)
40. Mothersill CE, O'Malley KJ, Murphy DM, Seymour CB, Lorimore SA, Wright EG. Identification and characterization of three subtypes of radiation response in normal human urothelial cultures exposed to ionizing radiation. Carcinogenesis 1999; 20:2273-8. (Pubitemid 30015898)
41. Mendonca MS, Howard KL, Farrington DL, Desmond LA, Temples TM, Mayhugh BM, et al. Delayed apoptotic responses associated with radiation-induced neoplastic transformation of human hybrid cells. Cancer Res 1999; 59:3972-9. (Pubitemid 29393564)
42. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2:725-34.
43. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammationassociated cancer. Nature 2004; 431:461-6. (Pubitemid 39329586)
44. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5:749-59. (Pubitemid 41400849)
45. Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 2004; 173:2011-22. (Pubitemid 38971638)
46. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19:711-21. (Pubitemid 28376759)
47. Neriishi K, Nakashima E, Delongchamp RR. Persistent subclinical inflammation among A-bomb survivors. Int J Radiat Biol 2001; 77:475-82. (Pubitemid 32281128)
48. Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene 2001 20 7085-95 (Pubitemid 33052200)
49. Hei TK, Zhou H, Ivanov VN, Hong M, Lieberman HB, Brenner DJ, et al. Mechanism of radiation-induced bystander effects: a unifying model. J Pharm Pharmacol 2008; 60:943-50.
50. Emerit I. Clastogenic factors: detection and assay. Methods Enzymol 1990; 186:555-64. (Pubitemid 20279998)
51. Spitz DR, Azzam EI, Li JJ, Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology. Cancer Metastasis Rev 2004; 23:311-22. (Pubitemid 38881814)
52. Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006; 99:132-40.
53. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332:1302-8.
54. Jiao W, Kiang JG, Cary L, Elliott TB, Pellmar TC, Ledney GD. COX-2 inhibitors are contraindicated for treatment of combined injury. Radiat Res 2009; 172:686-97.
55. Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 2009; 16:130-43.